About CanSinoBIO
Overview
Milestones
Management team
Culture and values
Contact us
Scientific advisory board
News
Corporate news
Industry news
Development And Product
Areas of focus
Pipeline
Technology platforms
Partnership
Our fight against Covid-19
Investor Relations
Information disclosure
Stock information
Corporate governance
Calendar
Investor enquiries
Information request
Careers
Talent philosophy
Benefits
Contact Us
FAQ
Contact information
Search
Subscribe
当前位置:
首页
新闻详情
Obtained approval to conduct a clinical trial for inhaled version of COVID-19 vaccine in China
2021-03
Subscribe
